July 28, 2016 2:11 AM ET

Life Sciences Tools and Services

Company Overview of Wolfe Laboratories, Inc.

Company Overview

Wolfe Laboratories, Inc. provides contract research and development services to the pharmaceutical and biotechnology industries. The company specializes in pre-clinical formulation development for small molecules, proteins, and peptides as solutions and dispersed systems. It offers various pre-clinical services, including pre-formulation and formulation development, analytical method development and characterization, PK and in vitro ADME bioanalytical development, dose formulation stability and uniformity assessment, and lyophilization services. The company was founded in 1999 and is based in Watertown, Massachusetts.

134 Coolidge Avenue

Watertown, MA 02472

United States

Founded in 1999

Phone:

617-923-7600

Fax:

617-923-7611

Key Executives for Wolfe Laboratories, Inc.

Founder, Chief Executive Officer and President
Senior Vice President and General Counsel
Vice President of Pharmaceutical Development
Compensation as of Fiscal Year 2016.

Wolfe Laboratories, Inc. Key Developments

Wolfe Laboratories, Inc. Announces the Appointment of Frank Tagliaferri as Vice President, Pharmaceutical Development, Effective Immediately

Wolfe Laboratories, Inc. announced that Frank Tagliaferri, Ph.D., has been appointed Vice President, Pharmaceutical Development, effective immediately. Dr. Tagliaferri will lead technical operations for Wolfe’s rapidly growing client base, bringing a wealth of experience in analytical methodologies, formulation and process development, scale-up, and regulatory functions across highly diverse therapeutic modalities, including small molecules, peptides, proteins, and nucleic acid therapeutics. Dr. Tagliaferri will serve as a member of Wolfe’s executive leadership team and will report to Janet Wolfe, the company's President and Chief Executive Officer. Most recently, Dr. Tagliaferri co-founded and served as Vice President of R&D at 4P Therapeutics with a focus on the design, characterization, and commercial development of novel delivery systems and drug/device combination products for biologics and other complex molecules.

Paul Oakley Joins Wolfe Laboratories, Inc. as Senior Vice President and General Counsel

Wolfe Laboratories, Inc. announced the expansion of its senior management team through the addition of Paul Oakley, who has joined as Senior Vice President and General Counsel. In this role, Mr. Oakley will be responsible for the company’s corporate and financial strategies and general operations. Mr. Oakley will be reporting to Janet Wolfe, President and CEO of Wolfe Laboratories. Mr. Oakley brings more than 20 years of experience as an executive and entrepreneur, building and managing high-growth, mission-oriented teams and organizations, as well as an external general counsel for a vast portfolio of emerging growth companies. Prior to joining Wolfe, Mr. Oakley served as Chief Administrative Officer for Truelight, LLC. He was also responsible for delivering analytics and business intelligence solutions to the $78 billion-and-growing competitive retail electricity supply sector and to the multi-billion-dollar clean energy development community through its subsidiary, TrueLight Energy, LLC.

Wolfe Laboratories, Inc. Expands its Integrated Pharmaceutical Development Operations

Wolfe Laboratories, Inc. announced its expansion of the company's analytical, formulation and process development capabilities. The company has relocated to its 17,595 square feet of laboratory and office space at 19 Presidential Way in Woburn, Massachusetts. The expansion builds upon company’ existing pharmaceutical development capabilities, and will support continued innovation in the development of small molecules, biologics, antibody drug conjugates and nucleic acid therapeutics. The company’s clients depend upon its expeditious scientific acumen of their development programs, which support IND enabling, clinical advancement and commercialization of innovative drug products.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Wolfe Laboratories, Inc., please visit www.wolfelabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.